Calendar · pharmadog

Sign In Subscribe

Week of Jan 26, 2026

50

Jan 30, 2026approval193d agoZYPREXA ZYDIS (OLANZAPINE) — FDA approvalDR REDDYS LABORATORIES LTD

Sponsor: CHEPLAPHARM. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL

full page →fda approvals ↗

Jan 30, 2026approval193d agoBRIVARACETAM — FDA approvalUCB SA

Sponsor: SUNSHINE. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Jan 30, 2026approval193d agoBRIVARACETAM — FDA approvalUCB SA

Sponsor: SUNSHINE. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Jan 30, 2026approval193d agoZYPREXA RELPREVV (OLANZAPINE PAMOATE) — FDA approvalCHEPLAPHARM Arzneimittel GmbH

Sponsor: CHEPLAPHARM. Form: SUSPENSION, EXTENDED RELEASE. Route: INTRAMUSCULAR

full page →fda approvals ↗

Jan 30, 2026approval193d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalUNASYN

Sponsor: SANDOZ. Form: INJECTABLE. Route: INJECTION

full page →UNASYN →fda approvals ↗

Jan 30, 2026approval193d agoZYPREXA (OLANZAPINE) — FDA approvalTEVA PHARMACEUTICAL INDUSTRIES LTD

Sponsor: CHEPLAPHARM. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Jan 30, 2026approval193d agoARSENIC TRIOXIDE — FDA approvalQuetzal Therapeutics LLC

Sponsor: EUGIA PHARMA. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Jan 30, 2026approval193d agoEPIRUBICIN HYDROCHLORIDE — FDA approvalEPIRUBICIN HYDROCHLORIDE

Sponsor: CIPLA LTD. Form: INJECTABLE. Route: INJECTION

full page →EPIRUBICIN HYDROCHLORIDE →fda approvals ↗

Jan 30, 2026approval193d agoAMOXICILLIN AND CLAVULANATE POTASSIUM (AMOXICILLIN) — FDA approvalHikma Pharmaceuticals Plc

Sponsor: HIKMA PHARMS. Form: FOR SUSPENSION. Route: ORAL

full page →fda approvals ↗

Jan 30, 2026approval193d agoOLANZAPINE AND FLUOXETINE HYDROCHLORIDE (FLUOXETINE HYDROCHLORIDE) — FDA approvalEpic Pharma LLC

Sponsor: PH HEALTH. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Jan 30, 2026approval193d agoLIVDELZI (SELADELPAR LYSINE) — FDA approvalseladelpar lysine

Sponsor: GILEAD SCIENCES INC. Form: CAPSULE. Route: ORAL

full page →seladelpar lysine →fda approvals ↗

Jan 30, 2026approval193d agoLATANOPROST — FDA approvalXalatan

Sponsor: EPIC PHARMA LLC. Form: SOLUTION/DROPS. Route: OPHTHALMIC

full page →Xalatan →fda approvals ↗

Jan 30, 2026approval193d agoLATANOPROST — FDA approvalXalatan

Sponsor: EPIC PHARMA LLC. Form: SOLUTION/DROPS. Route: OPHTHALMIC

full page →Xalatan →fda approvals ↗

Jan 30, 2026approval193d agoLATANOPROST — FDA approvalXalatan

Sponsor: EPIC PHARMA LLC. Form: SOLUTION/DROPS. Route: OPHTHALMIC

full page →Xalatan →fda approvals ↗

Jan 30, 2026approval193d agoEMTRICITABINE, RILPIVIRINE, AND TENOFOVIR ALAFENAMIDE (EMTRICITABINE) — FDA approvalemtricitabine

Sponsor: APOTEX. Form: TABLET. Route: ORAL

full page →emtricitabine →fda approvals ↗

Jan 30, 2026approval193d agoZYPREXA (OLANZAPINE) — FDA approvalTEVA PHARMACEUTICAL INDUSTRIES LTD

Sponsor: CHEPLAPHARM. Form: POWDER. Route: INTRAMUSCULAR

full page →fda approvals ↗

Jan 30, 2026approval193d agoLAMOTRIGINE — FDA approvalLAMOTRIGINE

Sponsor: ALEMBIC. Form: TABLET, FOR SUSPENSION. Route: ORAL

full page →LAMOTRIGINE →fda approvals ↗

Jan 30, 2026approval193d agoLAMOTRIGINE — FDA approvalLAMOTRIGINE

Sponsor: ALEMBIC. Form: TABLET, FOR SUSPENSION. Route: ORAL

full page →LAMOTRIGINE →fda approvals ↗

Jan 30, 2026approval193d agoLAMOTRIGINE — FDA approvalLAMOTRIGINE

Sponsor: ALEMBIC. Form: TABLET, FOR SUSPENSION. Route: ORAL

full page →LAMOTRIGINE →fda approvals ↗

Jan 30, 2026approval193d agoLAMOTRIGINE — FDA approvalLAMOTRIGINE

Sponsor: ALEMBIC. Form: TABLET, FOR SUSPENSION. Route: ORAL

full page →LAMOTRIGINE →fda approvals ↗

Jan 30, 2026approval193d agoLAMOTRIGINE — FDA approvalLAMOTRIGINE

Sponsor: ALEMBIC. Form: TABLET, FOR SUSPENSION. Route: ORAL

full page →LAMOTRIGINE →fda approvals ↗

Jan 30, 2026approval193d agoOLANZAPINE AND FLUOXETINE HYDROCHLORIDE (FLUOXETINE HYDROCHLORIDE) — FDA approvalEpic Pharma LLC

Sponsor: TEVA PHARMS. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Jan 30, 2026approval193d agoLYBALVI (OLANZAPINE) — FDA approval(olanzapine + samidorphan l-malate)

Sponsor: ALKERMES INC. Form: TABLET. Route: ORAL

full page →(olanzapine + samidorphan l-malate) →fda approvals ↗

Jan 30, 2026approval193d agoVENLAFAXINE HYDROCHLORIDE — FDA approvalViatris Inc

Sponsor: PLATINUM. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

full page →fda approvals ↗

Jan 30, 2026approval193d agoCETIRIZINE HYDROCHLORIDE ALLERGY (CETIRIZINE HYDROCHLORIDE) — FDA approvalCETIRIZINE HYDROCHLORIDE

Sponsor: BIONPHARMA. Form: CAPSULE. Route: ORAL

full page →CETIRIZINE HYDROCHLORIDE →fda approvals ↗

Jan 30, 2026approval193d agoDAPTOMYCIN — FDA approvalDaptomycin Novo

Sponsor: MEITHEAL. Form: POWDER. Route: INTRAVENOUS

full page →Daptomycin Novo →fda approvals ↗

Jan 30, 2026approval193d agoOZEMPIC (SEMAGLUTIDE) — FDA approvalNovo Nordisk AS

Sponsor: NOVO. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Jan 30, 2026approval193d agoOLANZAPINE AND FLUOXETINE HYDROCHLORIDE (FLUOXETINE HYDROCHLORIDE) — FDA approvalEpic Pharma LLC

Sponsor: TEVA PHARMS. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Jan 30, 2026approval193d agoENBREL (ETANERCEPT) — FDA approvalAMGEN INC

Sponsor: IMMUNEX. Form: SYRINGE

full page →fda approvals ↗

Jan 30, 2026approval193d agoVALACYCLOVIR HYDROCHLORIDE — FDA approvalVALACYCLOVIR HYDROCHLORIDE

Sponsor: JUBILANT GENERICS. Form: TABLET. Route: ORAL

full page →VALACYCLOVIR HYDROCHLORIDE →fda approvals ↗

Jan 30, 2026grant193d agoGORDON RESEARCH CONFERENCES — 2026 Atomically Precise Nanochemistry Gordon Research Conference and Gordon R...

EB grant. $7,140. PI: Stacy Marla Copp

full page →nih reporter ↗

Jan 30, 2026grant193d agoUNIVERSITY OF DELAWARE — Understanding linguistic differences in mild cognitive impairment: The import...

AG grant. $46,086. PI: Anna Saylor

full page →nih reporter ↗

Jan 30, 2026grant193d agoUNIVERSITY OF PENNSYLVANIA — What interventions to reduce hospital nurse burnout are most effective?University of Pennsylvania

NR grant. $1,422,387. PI: EILEEN T LAKE

full page →nih reporter ↗

Jan 31, 2026grant192d agoUNIVERSITY OF MINNESOTA — Paraventricular Nucleus of the Thalamus and Nucleus Accumbens Neurons in Aver...University of Minnesota

AA grant. $78,520. PI: Meredith Rose Bauer

full page →nih reporter ↗

Feb 1, 2026grant191d agoUNIVERSITY OF PENNSYLVANIA — Project 4: Chromatin basis of cellular senescence and tissue agingUniversity of Pennsylvania

AG grant. $401,404. PI: Rugang Zhang

full page →nih reporter ↗

Feb 1, 2026grant191d agoOHIO STATE UNIVERSITY — Energy balance, mTOR pathway signaling, and breast cancer prognosis

CA grant. $766,371. PI: Ting-Yuan Cheng

full page →nih reporter ↗

Feb 1, 2026grant191d agoUNIVERSITY OF VIRGINIA — Myeloid Cell Regulation of Cerebrovascular Basal and Functional ToneUniversity of Virginia

NS grant. $242,250. PI: Ukpong Bassey Eyo

full page →nih reporter ↗

Feb 1, 2026grant191d agoUNIVERSITY OF CALIFORNIA, SAN DIEGO — Lympnoids tissue senescence and multimodal imaging using REDCATUniversity of California San Diego

AG grant. $700,795. PI: VISHWA DEEP DIXIT

full page →nih reporter ↗

Feb 1, 2026grant191d agoUNIVERSITY OF CALIFORNIA, SAN FRANCISCO — Impact of Pathological Tau on Circuit Function in Phenotypic Mouse Models of ...University of California San Francisco

NS grant. $136,620. PI: Rose Berthe Creed

full page →nih reporter ↗

Feb 1, 2026grant191d agoMEDICAL COLLEGE OF WISCONSIN — p66Shc in Cerebrovascular Impairment in Alzheimer’s Disease

AG grant. $441,460. PI: Fan Fan

full page →nih reporter ↗

Feb 1, 2026grant191d agoDUKE UNIVERSITY — Defining cellular and molecular signatures of inflammation in people with sup...Duke University

DK grant. $832,783. PI: Todd Christopher Bradley

full page →nih reporter ↗

Feb 1, 2026grant191d agoWEST VIRGINIA UNIVERSITY — Tubulinopathy and visual disorders

GM grant. $243,046. PI: Eric James Horstick

full page →nih reporter ↗

Feb 1, 2026grant191d agoNORTHWESTERN UNIVERSITY AT CHICAGO — Clinical, Anatomic, and Pathologic Spread of Semantic Language Impairment in ...Northwestern University

AG grant. $49,538. PI: Allegra Kawles

full page →nih reporter ↗

Feb 1, 2026grant191d agoSOUTH DAKOTA STATE UNIVERSITY — Defining the function of spatiotemporal JNK activation in cell fate determina...

GM grant. $264,270. PI: Ryan L Hanson

full page →nih reporter ↗

Feb 1, 2026grant191d agoUNIV OF ARKANSAS FOR MED SCIS — Roles of Hsp47 in breast cancer progression

CA grant. $267,208. PI: Ren Xu

full page →nih reporter ↗

Feb 1, 2026grant191d agoOREGON HEALTH & SCIENCE UNIVERSITY — Development of Long-Acting Antiretroviral Therapy for Sustained SIV Suppressi...

AI grant. $482,625. PI: Jonah B. Sacha

full page →nih reporter ↗

Feb 1, 2026grant191d agoUNIVERSITY OF KENTUCKY — Evaluation of Noninvasive Muscle Imaging Biomarkers for Knee Osteoarthritis i...

AG grant. $666,504. PI: Christopher Fry

full page →nih reporter ↗

Feb 1, 2026grant191d agoUTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH — Cholesterol Metabolism in Regulatory T cell FunctionUniversity of Utah

AI grant. $423,500. PI: Maria Bettini

full page →nih reporter ↗

Feb 1, 2026grant191d agoKEYSTONE SYMPOSIA — Aging: Immune Function and Organ Health

AG grant. $19,600. PI: TERRY L. SHEPPARD

full page →nih reporter ↗

Feb 1, 2026grant191d agoBROWN UNIVERSITY — Brown Moi Partnership for Biostatistics Training in HIV-NAMBARI

TW grant. $185,185. PI: JOSEPH W HOGAN

full page →nih reporter ↗

← prev

page 1 of 59